What is the CJC-1295 half life in people?

Where did the CJC-1295 half life come from?

The CJC-1295 half life is the time needed for half to clear from blood. For long-form DAC, that time was 5.8-8.1 days. Healthy adults received 30 or 60 ug/kg once. Their average growth hormone rose 2- to 10-fold, meaning at least twice and at most ten times its starting level ^[1].

IGF-1, a growth-linked blood protein, rose 1.5- to 3-fold, meaning the new level was between its start plus half and three times its start. This long rise separates DAC from no-DAC. Because the study was small, your answer applies only to those adults.

DAC joins CJC-1295 to albumin, one of the main blood proteins ^[2]. Albumin clears slowly. In rats, the joined drug remained after 72 hours ^[2]. That rat result led to later tests in people.

How long did the IGF-1 growth blood test stay raised?

<a id="sustained"></a>

After repeated shots, IGF-1 remained above its starting level. The higher level was still present at 28 days ^[1]. After one shot, IGF-1 was about 45% higher one week later ^[3]. The rise did not fade at once.

Growth hormone still rose several times each day. Those brief rises kept their usual number and size. The day's lowest growth-hormone level rose about 7.5-fold, meaning seven times its start, plus half again ^[3]. That result came from a brief, small study.

The study measured blood levels, not better health. It didn't prove greater strength or less body fat. Your doctor can't treat the result as a sure benefit. Only longer tests could answer more.

How does a blood protein keep the drug there longer?

<a id="mechanism-pk"></a>

DAC is a joining part on the drug. It binds the drug to albumin, a large blood protein ^[2]. Albumin clears more slowly than the free chain. The attached drug travels with albumin.

A kilodalton is a protein weight unit, much as a pound is for people; the free chain weighs about 3.4 kilodaltons, and the joined pair weighs about 66 kilodaltons. The free chain is far lighter. The size gap helps explain the longer stay. Weight alone does not prove safety.

Four altered spots also slow breakdown ^[2]. In rats, the joined drug remained in blood after 72 hours. Over two hours, total growth hormone was 4-fold higher than with the unaltered chain, meaning four times as much in the same span ^[2]. In people, half the drug cleared in 5.8-8.1 days ^[1].

Why does the no-DAC form leave sooner?

<a id="no-dac-pk"></a>

The no-DAC form lacks the albumin link. It keeps four changes that slow one kind of breakdown ^[16]. Without albumin, the drug leaves within minutes to hours. The longer DAC time doesn't apply ^[16][2].

That is why CJC-1295 DAC vs no-DAC matters. A source needs to name the form. Half the DAC form left blood in 5.8-8.1 days, while no-DAC left sooner ^[1][16]. The CJC-1295 name alone won't settle your question.

Even the long form had limits in mice. A 2 ug shot each day brought growth back. A 48-to-72-hour gap worked less well ^[4]. Mouse growth doesn't tell your doctor what happens in a person.

What limits come with the time results?

<a id="route-limits"></a>

The main studies gave CJC-1295 by a shot just beneath the skin ^[1]. Earlier tests put the short, unaltered chain into a vein. The stomach would break down this peptide, or short protein chain ^[2]. No swallowed form has a measured time in blood.

One 2006 study followed a modest group of healthy adults. A second 2006 study did the same ^[1][3]. Neither was large or long. People results end at the 28-day IGF-1 blood check.

CJC-1295 isn't approved for people. The figures apply only to the study groups. They don't promise what would happen to you. The full reference list shows the source for each result.